Profil
Anne Walker is currently an Independent Director at Warburg Pincus Capital Corp.
I-B and the Chief Financial Officer & Executive Vice President at Repertoire Immune Medicines, Inc. Previously, she held positions as a Non-Executive Director at Markit Ltd. and Head-Enterprise Strategic Initiatives at Bank of America Corp.
Ms. Walker received an undergraduate degree from Harvard University and an MBA from Columbia Business School.
Postes actifs de Anne Walker
| Sociétés | Poste | Début |
|---|---|---|
| WARBURG PINCUS CAPITAL CORPORATION I-B | Directeur/Membre du Conseil | 25/08/2021 |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Directeur Financier/CFO | 01/06/2021 |
Anciens postes connus de Anne Walker
| Sociétés | Poste | Fin |
|---|---|---|
| BANK OF AMERICA CORPORATION | Corporate Officer/Principal | - |
Markit Ltd.
Markit Ltd. Data Processing ServicesTechnology Services Provides financial information | Directeur/Membre du Conseil | - |
Formation de Anne Walker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Bank of America Corp.
Bank of America Corp. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer and global banking, markets brokerage & wealth and investment management services | Finance |
Markit Ltd.
Markit Ltd. Data Processing ServicesTechnology Services Provides financial information | Technology Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
Warburg Pincus Capital Corp. I-B
Warburg Pincus Capital Corp. I-B Financial ConglomeratesFinance Operates as a blank check company | Finance |
















